Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers.

Roberts, Maegan E; Ranola, John Michael O; Marshall, Megan L; Susswein, Lisa R; Graceffo, Sara; Bohnert, Kelsey; Tsai, Ginger; Klein, Rachel T; Hruska, Kathleen S; Shirts, Brian H

Roberts, Maegan E; Ranola, John Michael O; Marshall, Megan L; Susswein, Lisa R; Graceffo, Sara; Bohnert, Kelsey; Tsai, Ginger; Klein, Rachel T; Hruska, Kathleen S; Shirts, Brian H.

Afiliação

Roberts ME; GeneDx, Gaithersburg, Maryland.
Ranola JMO; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
Marshall ML; GeneDx, Gaithersburg, Maryland.
Susswein LR; GeneDx, Gaithersburg, Maryland.
Graceffo S; GeneDx, Gaithersburg, Maryland.
Bohnert K; GeneDx, Gaithersburg, Maryland.
Tsai G; Genetic Counseling Program, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.
Klein RT; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
Hruska KS; My Gene Team, Miami, Florida.
Shirts BH; GeneDx, Gaithersburg, Maryland.

JAMA Oncol ; 5(9): 1325-1331, 2019 Sep 01.

Article em En | MEDLINE | ID: mdl-31246251

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: JAMA Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google